Freedom Biosciences Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 8

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 22

Freedom Biosciences General Information

Description

Developer of a biotechnology platform designed for next-generation psychedelic therapeutics. The company offers ketamine-based therapies and combinations of neuropsychiatric drugs to create neuropsychiatric treatments for mental health and substance use disorders, enabling patients suffering from depression, PTSD, and other disorders to access more effective and safer treatment options.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 52 Lagoon Vista Road
  • Tiburon, CA 94920
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 52 Lagoon Vista Road
  • Tiburon, CA 94920
  • United States

Freedom Biosciences Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Freedom Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC 01-Nov-2026 Completed Clinical Trials - General
3. Early Stage VC (Series A) 01-Mar-2025 Completed Clinical Trials - General
2. Accelerator/Incubator 25-Feb-2025 $10.5M Completed Clinical Trials - General
1. Seed Round 23-Aug-2022 $10.5M $10.5M Completed Clinical Trials - General
To view Freedom Biosciences’s complete valuation and funding history, request access »

Freedom Biosciences Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
To view Freedom Biosciences’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Freedom Biosciences Patents

Freedom Biosciences Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025259805-A1 Treatment of depressive disorder through combination therapy Pending 12-Jun-2024
WO-2024178082-A2 Composition of opioid receptor modulator and mdma for use thereof Inactive 22-Feb-2023
WO-2024178082-A3 Composition of opioid receptor modulator and mdma for use thereof Inactive 22-Feb-2023
AU-2023390101-A1 Treatment or prevention of depressive disorders through combination therapy Pending 07-Dec-2022
EP-4629989-A2 Treatment or prevention of depressive disorders through combination therapy Pending 07-Dec-2022 A61K9/08
To view Freedom Biosciences’s complete patent history, request access »

Freedom Biosciences Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Freedom Biosciences Investors (22)

Investor Name Investor Type Holding Investor Since Participating Rounds
Paragon Equity Partners PE/Buyout Minority
Evolution VC Partners Venture Capital Minority
Gaingels Venture Capital Minority
Hoodoo Ventures Venture Capital Minority
LongeVC Venture Capital Minority
You’re viewing 5 of 22 investors. Get the full list »

Freedom Biosciences FAQs

  • When was Freedom Biosciences founded?

    Freedom Biosciences was founded in 2021.

  • Where is Freedom Biosciences headquartered?

    Freedom Biosciences is headquartered in Tiburon, CA.

  • What is the size of Freedom Biosciences?

    Freedom Biosciences has 8 total employees.

  • What industry is Freedom Biosciences in?

    Freedom Biosciences’s primary industry is Drug Discovery.

  • Is Freedom Biosciences a private or public company?

    Freedom Biosciences is a Private company.

  • What is Freedom Biosciences’s current revenue?

    The current revenue for Freedom Biosciences is .

  • How much funding has Freedom Biosciences raised over time?

    Freedom Biosciences has raised $27.7M.

  • Who are Freedom Biosciences’s investors?

    Paragon Equity Partners, Evolution VC Partners, Gaingels, Hoodoo Ventures, and LongeVC are 5 of 22 investors who have invested in Freedom Biosciences.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process